hepatitis B

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.


Maker of Hepatitis B antiviral raises $9M

There’s been a lot of hype around new Hep C drugs (cough, Gilead, cough), but less attention’s paid to Hepatitis B, a stunningly prevalent version of the virus that can lead to cirrhosis and liver cancer. Novira Therapeutics just raised $9 million in debt from 10 investors, according to a regulatory filing. The startup last year […]


JNJ, BioCrossroads invest in Hoosier pharma startup at work on potential hepatitis B cure

An Indiana University spinout attracted investors from Johnson & Johnson Development Corp. and BioCrossroads with novel drugs to treat, and even potentially cure, patients with hepatitis B. Assembly Pharmaceuticals received an undisclosed amount for this seed round. This funding will finance the preclinical proof of concept and help the company establish its bio labs in San Francisco, […]